<DOC>
	<DOCNO>NCT01446523</DOCNO>
	<brief_summary>The purpose study examine S.endotoxins , inflammatory mediator Magnetic Resonance Spectroscopy ( MRS ) treatment patient cirrhosis minimal hepatic encephalopathy .</brief_summary>
	<brief_title>S. Endotoxin , Inflammatory Mediators MRS Before After Treatment MHE</brief_title>
	<detailed_description>60 patient cirrhosis Minimal Hepatic Encephalopathy ( MHE ) fulfill inclusion &amp; exclusion criterion part study . Study patient divide two group ( n=30 group ) . Group L patient receive lactulose therapy Group NL receive placebo . After 3 month , S.endotoxins , inflammatory mediator MRS repeat group .</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>Clinical diagnosis Cirrhosis ( Age 15 yr 70 yr ) Recent history gastrointestinal bleed last 6 week Active ongoing infection Creatinine &gt; 1.5mg % Electrolyte impairment . ( S. Sodium &lt; 130 meq/L , S. Potassium 3.5 meq/L &gt; 5.0meq/L ) H/O use psychotropic drug last 6 week Recent alcohol use ( &lt; 6 week ) H/O TIPS shunt surgery . Hepatocellular Carcinoma Severe comorbidity Congestive Heart Failure , Pulmonary disease , Neurological Psychiatric problem impair quality life Poor vision preclude neuropsychological assessment</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>endotoxin HE</keyword>
</DOC>